Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Oct. 15, 2021—Beckman Coulter launched at this year’s AACC Annual Scientific Meeting and Clinical Lab Expo its DxU Iris Workcell, a fully automated system designed for high-volume laboratories that streamlines urinalysis workflow and reduces manual reviews to four percent.
Oct. 13, 2021—PerkinElmer announced that the FDA has issued emergency use authorization for its PKamp Respiratory SARS-CoV-2 RT-PCR Panel 1 assay.
Oct. 11, 2021—Bio-Rad announced its Exact Diagnostics RP Positive Run Control for syndromic respiratory panels is now available with inactivated whole virus for SARS-CoV-2.
Oct. 1, 2021—Sysmex America has introduced its XN-30 research use only automated hematology analyzer for malaria detection. The analyzer differentiates P. falciparum from non-falciparum species and determines the life-cycle staging of the parasites detected.
Sept. 30, 2021—Bio-Rad Laboratories launched its Bio-Plex Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens.
Sept. 29, 2021—Seegene unveiled its first fully automated PCR testing system, Starlet-AIOS, at the 2021 AACC annual meeting, Sept. 26–30, in Atlanta.
Sept. 23, 2021—The FDA authorized marketing of Paige’s software Paige Prostate, a prostate cancer detection solution that identifies foci suspicious for cancer and provides this information to a pathologist.
Sept. 21, 2021—DiaSorin Molecular announced that it has CE marked its Simplexa COVID-19 and Flu A/B Direct kit.
Sept. 20, 2021—MeMed announced FDA 510(k) clearance for use of the company’s MeMed BV test on the MeMed Key platform to help health care providers distinguish between bacterial and viral infections.
Aug. 31, 2021—PreciseMDX introduced a cloud-based solution that enables labs to set up scalable, personalized, digital experiences.
